EP2359866B1
(en)
*
|
2005-04-07 |
2013-07-17 |
The Trustees of The University of Pennsylvania |
Modified AAV rh48 capsids, compositions containing same and uses thereof
|
US9725485B2
(en)
|
2012-05-15 |
2017-08-08 |
University Of Florida Research Foundation, Inc. |
AAV vectors with high transduction efficiency and uses thereof for gene therapy
|
WO2008124724A1
(en)
|
2007-04-09 |
2008-10-16 |
University Of Florida Research Foundation, Inc. |
Raav vector compositions having tyrosine-modified capsid proteins and methods for use
|
WO2010138263A2
(en)
|
2009-05-28 |
2010-12-02 |
University Of Massachusetts |
Novel aav 's and uses thereof
|
MX2013012599A
(es)
|
2011-04-29 |
2014-08-21 |
Selecta Biosciences Inc |
Liberación controlada de inmunosupresores a partir de nanoportadores sintéticos.
|
PE20150163A1
(es)
|
2012-04-18 |
2015-02-23 |
Philadelphia Children Hospital |
Composicion y metodos para una transferencia de genes altamente eficiente usando variantes capside aav
|
US10294281B2
(en)
|
2012-05-15 |
2019-05-21 |
University Of Florida Research Foundation, Incorporated |
High-transduction-efficiency rAAV vectors, compositions, and methods of use
|
US12358954B2
(en)
|
2012-05-15 |
2025-07-15 |
University Of Florida Research Foundation, Incorporated |
Capsid-modified rAAV vector compositions and methods therefor
|
CA2907799A1
(en)
*
|
2013-05-31 |
2014-12-04 |
The Regents Of The University Of California |
Adeno-associated virus variants and methods of use thereof
|
MY175477A
(en)
*
|
2013-07-22 |
2020-06-30 |
Childrens Hospital Philadelphia |
Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
|
US20160369298A1
(en)
|
2013-09-26 |
2016-12-22 |
University Of Florida Research Foundation, Inc. |
Synthetic combinatorial aav capsid library for targeted gene therapy
|
GB201403684D0
(en)
*
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
WO2015134643A1
(en)
*
|
2014-03-04 |
2015-09-11 |
University Of Florida Research Foundation, Inc. |
Improved raav vectors and methods for transduction of photoreceptors and rpe cells
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
CA2957737A1
(en)
|
2014-09-07 |
2016-03-10 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
|
EP3209311B1
(en)
|
2014-10-21 |
2024-03-06 |
University of Massachusetts |
Recombinant aav variants and uses thereof
|
CN107106689A
(zh)
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
KR20230169197A
(ko)
|
2014-11-14 |
2023-12-15 |
보이저 테라퓨틱스, 인크. |
근위축성 측삭 경화증(als)을 치료하는 조성물 및 방법
|
KR102584655B1
(ko)
|
2014-11-14 |
2023-10-06 |
보이저 테라퓨틱스, 인크. |
조절성 폴리뉴클레오티드
|
EP3230441A4
(en)
|
2014-12-12 |
2018-10-03 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
WO2016126857A1
(en)
|
2015-02-03 |
2016-08-11 |
University Of Florida Research Foundation, Inc. |
Recombinant aav1, aav5, and aav6 capsid mutants and uses thereof
|
WO2016133917A1
(en)
|
2015-02-16 |
2016-08-25 |
University Of Florida Research Foundation |
Raav vector compositions, methods for targeting vascular endothelial cells and use in treatment of type i diabetes
|
WO2016134337A1
(en)
*
|
2015-02-19 |
2016-08-25 |
University Of Florida Research Foundation, Inc. |
Site-specific integrating recombinant aav vectors for gene therapy and improved production methods
|
JP6519080B2
(ja)
*
|
2015-06-22 |
2019-05-29 |
ライオン株式会社 |
繊維製品用抗ウイルス組成物
|
EP3313991B1
(en)
|
2015-06-23 |
2024-07-17 |
The Children's Hospital of Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
CN114606267A
(zh)
|
2015-09-28 |
2022-06-10 |
北卡罗来纳-查佩尔山大学 |
逃避抗体的病毒载体的方法和组合物
|
US12188037B2
(en)
|
2015-10-22 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Synthetic combinatorial AAV3 capsid library
|
AU2016344065A1
(en)
|
2015-10-28 |
2018-05-10 |
The Trustees Of The University Of Pennsylvania |
Intrathecal administration of adeno-associated-viral vectors for gene therapy
|
PE20231949A1
(es)
|
2015-10-30 |
2023-12-05 |
Spark Therapeutics Inc |
VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA
|
CA3006569A1
(en)
|
2015-12-02 |
2017-06-08 |
Voyager Therapeutics, Inc. |
Assays for the detection of aav neutralizing antibodies
|
WO2017181162A1
(en)
*
|
2016-04-16 |
2017-10-19 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
US11299751B2
(en)
|
2016-04-29 |
2022-04-12 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
BR112018072849B1
(pt)
|
2016-05-13 |
2020-12-22 |
4D Molecular Therapeutics Inc. |
proteína de capsídeo variante de vírus adeno-associado, ácido nucleico isolado, vírion de raav infeccioso e respectivo uso e composição farmacêutica
|
JP7066635B2
(ja)
|
2016-05-18 |
2022-05-13 |
ボイジャー セラピューティクス インコーポレイテッド |
調節性ポリヌクレオチド
|
US11951121B2
(en)
|
2016-05-18 |
2024-04-09 |
Voyager Therapeutics, Inc. |
Compositions and methods for treating Huntington's disease
|
CR20190127A
(es)
*
|
2016-08-15 |
2019-06-25 |
Genzyme Corp |
Métodos para detectar aav
|
JP2019531787A
(ja)
|
2016-08-30 |
2019-11-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
生物医学的ターゲティング及びデリバリーの方法並びにそれを実行するための装置及びシステム
|
JP7577291B6
(ja)
*
|
2016-10-13 |
2024-11-26 |
ユニバーシティ オブ マサチューセッツ |
Aavカプシド設計
|
WO2018129268A1
(en)
|
2017-01-07 |
2018-07-12 |
Selecta Biosciences, Inc. |
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
|
CN110462037A
(zh)
*
|
2017-01-30 |
2019-11-15 |
学校法人日本医科大学 |
腺相关病毒(aav)衣壳蛋白的突变体
|
CA3114549A1
(en)
|
2017-02-21 |
2018-08-30 |
University Of Florida Research Foundation, Incorporated |
Modified aav capsid proteins and uses thereof
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
CA3055936A1
(en)
|
2017-03-11 |
2018-09-20 |
Selecta Biosciences, Inc. |
Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
|
WO2018170310A1
(en)
|
2017-03-15 |
2018-09-20 |
The University Of North Carolina At Chapel Hill |
Polyploid adeno-associated virus vectors and methods of making and using the same
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
DK3601367T3
(da)
|
2017-03-30 |
2025-01-13 |
Univ Queensland |
Kimære molekyler og anvendelse deraf
|
WO2018204803A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
CA3061652A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
AU2018281306B2
(en)
|
2017-06-07 |
2025-04-17 |
Spark Therapeutics, Inc. |
Enhancing agents for improved cell transfection and/or rAAV vector production
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
CN110461368A
(zh)
|
2017-06-30 |
2019-11-15 |
加利福尼亚大学董事会 |
具有变异衣壳的腺相关病毒病毒体及其使用方法
|
AU2018302016A1
(en)
|
2017-07-17 |
2020-02-06 |
The Regents Of The University Of California |
Trajectory array guide system
|
US20210228738A1
(en)
|
2017-07-17 |
2021-07-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
|
US12076369B2
(en)
|
2017-09-01 |
2024-09-03 |
The Frances Crick Institute Limited |
Immunoregulatory molecules and uses therefor
|
JP6825167B2
(ja)
|
2017-09-20 |
2021-02-03 |
4ディー モレキュラー セラピューティクス インコーポレイテッド |
アデノ随伴ウイルス変異キャプシドおよびその使用方法
|
US20200263199A1
(en)
|
2017-09-29 |
2020-08-20 |
Voyager Therapeutics, Inc. |
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
|
AU2018347583A1
(en)
|
2017-10-13 |
2020-05-21 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector IgM responses
|
JP7502991B2
(ja)
|
2017-10-16 |
2024-06-19 |
ボイジャー セラピューティクス インコーポレイテッド |
筋萎縮性側索硬化症(als)の治療
|
EP4454654A3
(en)
|
2017-10-16 |
2025-02-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
JP7184894B2
(ja)
|
2017-11-27 |
2022-12-06 |
4ディー モレキュラー セラピューティクス インコーポレイテッド |
アデノ随伴ウイルス変異キャプシドおよび血管新生の阻害のための使用
|
US11905533B2
(en)
|
2017-12-19 |
2024-02-20 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for delivery of viral vectors across the blood-brain barrier
|
WO2019152843A1
(en)
|
2018-02-01 |
2019-08-08 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
|
US10610606B2
(en)
|
2018-02-01 |
2020-04-07 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
|
EP3755795A4
(en)
|
2018-02-19 |
2022-07-20 |
Homology Medicines, Inc. |
Adeno-associated virus compositions for restoring f8 gene function and methods of use thereof
|
US12178908B2
(en)
|
2018-02-26 |
2024-12-31 |
AnTolRx, Inc. |
Tolerogenic liposomes and methods of use thereof
|
IL276859B1
(en)
*
|
2018-02-27 |
2025-08-01 |
Univ Pennsylvania |
Novel adeno-associated virus (AAV) vectors, AAV vectors with reduced capsid deamidation and uses therefor
|
CN111819286B
(zh)
*
|
2018-03-16 |
2024-05-24 |
国家儿童医院研究所 |
通过衣壳修饰增加组织特异性的基因递送
|
WO2019195449A1
(en)
|
2018-04-03 |
2019-10-10 |
Stridebio, Inc. |
Antibody-evading virus vectors
|
CN112543766A
(zh)
|
2018-04-03 |
2021-03-23 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
KR20210006358A
(ko)
|
2018-04-03 |
2021-01-18 |
스트라이드바이오 인코포레이티드 |
안 조직을 표적으로 하기 위한 바이러스 벡터
|
AU2019249890B2
(en)
|
2018-04-05 |
2024-10-10 |
Association Institut De Myologie |
Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
|
EP3784697A4
(en)
*
|
2018-04-27 |
2022-07-06 |
Spark Therapeutics, Inc. |
Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same
|
CA3098198A1
(en)
|
2018-04-27 |
2019-10-31 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
BR112020023082A2
(pt)
|
2018-05-15 |
2021-02-09 |
Voyager Therapeutics, Inc. |
composições e métodos para o tratamento de doença de parkinson
|
KR20210021310A
(ko)
*
|
2018-05-16 |
2021-02-25 |
스파크 테라퓨틱스, 인코포레이티드 |
코돈-최적화된 산 알파-글루코시다제 발현 카세트 및 이를 사용하는 방법
|
KR20210034015A
(ko)
|
2018-07-16 |
2021-03-29 |
셀렉타 바이오사이언시즈, 인크. |
Mma 구축물 및 벡터의 방법 및 조성물
|
CN112771070A
(zh)
|
2018-07-16 |
2021-05-07 |
西莱克塔生物科技公司 |
Otc构建体和载体的方法和组合物
|
US12281321B2
(en)
|
2018-09-28 |
2025-04-22 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
US11702673B2
(en)
|
2018-10-18 |
2023-07-18 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
TW202027799A
(zh)
|
2018-10-18 |
2020-08-01 |
美商英特利亞醫療公司 |
用於表現因子ix的組成物及方法
|
WO2020163743A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
JP7562544B2
(ja)
|
2019-02-08 |
2024-10-07 |
デシベル セラピューティクス インコーポレイテッド |
ミオシン15プロモーター及びその使用
|
CN113677801A
(zh)
|
2019-02-25 |
2021-11-19 |
诺华股份有限公司 |
治疗bietti晶体营养不良的组合物和方法
|
EP3931335A2
(en)
|
2019-02-25 |
2022-01-05 |
Novartis AG |
Compositions and methods to treat bietti crystalline dystrophy
|
AR118465A1
(es)
|
2019-03-21 |
2021-10-06 |
Stridebio Inc |
Vectores de virus adenoasociados recombinantes
|
BR112021021566A2
(pt)
|
2019-04-28 |
2022-04-19 |
Selecta Biosciences Inc |
Métodos para tratamento de indivíduos com imunidade preexistente a vetores de transferência viral
|
WO2020243261A1
(en)
|
2019-05-28 |
2020-12-03 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
RU2751592C2
(ru)
|
2019-08-22 |
2021-07-15 |
Общество С Ограниченной Ответственностью "Анабион" |
Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
|
EP4038194A1
(en)
|
2019-10-04 |
2022-08-10 |
Ultragenyx Pharmaceutical Inc. |
Methods for improved therapeutic use of recombinant aav
|
WO2021076925A1
(en)
|
2019-10-17 |
2021-04-22 |
Stridebio, Inc. |
Adeno-associated viral vectors for treatment of niemann-pick disease type c
|
IL294230A
(en)
|
2020-01-03 |
2022-08-01 |
Sarepta Therapeutics Inc |
Methods for analyzing aav capsid proteins
|
TW202140791A
(zh)
|
2020-01-13 |
2021-11-01 |
美商霍蒙拉奇醫藥公司 |
治療苯酮尿症之方法
|
CA3164714A1
(en)
|
2020-02-14 |
2021-08-19 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating cdkl5 deficiency disorder
|
EP4121544A1
(en)
|
2020-03-19 |
2023-01-25 |
Ultragenyx Pharmaceutical Inc. |
Compositions and methods for reducing reverse packaging of cap and rep sequences in recombinant aav
|
US20230129893A1
(en)
|
2020-03-31 |
2023-04-27 |
Ultragenyx Pharmaceutical Inc. |
Gene therapy for treating propionic acidemia
|
TW202208632A
(zh)
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復pah基因功能的腺相關病毒組成物及其使用方法
|
MX2023002016A
(es)
|
2020-08-19 |
2023-06-26 |
Sarepta Therapeutics Inc |
Vectores de virus adenoasociados para el tratamiento del sindrome de rett.
|
US12312606B2
(en)
|
2020-10-15 |
2025-05-27 |
Hoffmann-La Roche Inc. |
Nucleic acid constructs for VA RNA transcription
|
US20220154223A1
(en)
|
2020-10-15 |
2022-05-19 |
Hoffmann-La Roche Inc. |
Nucleic acid constructs for simultaneous gene activation
|
EP4274571A1
(en)
|
2021-01-05 |
2023-11-15 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
US20220347317A1
(en)
*
|
2021-04-23 |
2022-11-03 |
University Of Florida Research Foundation, Incorporated |
Aavrh74 vectors for gene therapy of muscular dystrophies
|
JP2024531138A
(ja)
|
2021-08-11 |
2024-08-29 |
ウルトラジェニックス ファーマシューティカル インコーポレイテッド |
筋ジストロフィーを処置するための組成物および方法
|
CN118139974A
(zh)
|
2021-08-20 |
2024-06-04 |
拜奥卡德联合股份公司 |
获得修饰的腺相关病毒衣壳的方法
|
AR126839A1
(es)
|
2021-08-20 |
2023-11-22 |
Llc «Anabion» |
Proteína de la cápside vp1 modificada aislada del virus adeno-asociado de serotipo 9 (aav9), cápside y vector basado en esta
|
AR126840A1
(es)
|
2021-08-20 |
2023-11-22 |
Llc «Anabion» |
Proteína de la cápside vp1 modificada aislada del virus adeno-asociado de serotipo 5 (aav5), cápside y vector basado en esta
|
US20230086710A1
(en)
*
|
2021-09-14 |
2023-03-23 |
California Institute Of Technology |
Aav capsid variants
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
EP4415760A1
(en)
|
2021-10-12 |
2024-08-21 |
Cartesian Therapeutics, Inc. |
Viral vector dosing protocols
|
CA3237037A1
(en)
|
2021-11-14 |
2023-05-19 |
Cartesian Therapeutics, Inc. |
Multiple dosing with viral vectors
|
CN116554278A
(zh)
*
|
2022-01-30 |
2023-08-08 |
上海玮美基因科技有限责任公司 |
变异型腺相关病毒及其在疾病治疗中的应用
|
EP4490278A1
(en)
|
2022-03-07 |
2025-01-15 |
Ultragenyx Pharmaceutical Inc. |
Modified batch aav production systems and methods
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
CN118974274A
(zh)
|
2022-04-13 |
2024-11-15 |
豪夫迈·罗氏有限公司 |
用于确定aav基因组的方法
|
CN119654334A
(zh)
*
|
2022-05-11 |
2025-03-18 |
费城儿童医院 |
用于靶向深层脑结构的腺相关病毒载体
|
CN119256220A
(zh)
|
2022-05-23 |
2025-01-03 |
豪夫迈·罗氏有限公司 |
用于区分aav颗粒血清型和aav颗粒荷载状态的基于拉曼的方法
|
JP2025519228A
(ja)
|
2022-06-03 |
2025-06-24 |
エフ. ホフマン-ラ ロシュ アーゲー |
組換えaav粒子を生成するための方法
|
KR20250036743A
(ko)
|
2022-07-14 |
2025-03-14 |
에프. 호프만-라 로슈 아게 |
재조합 aav 입자를 생산하는 방법
|
AU2023321906A1
(en)
|
2022-08-11 |
2025-03-27 |
Cartesian Therapeutics, Inc. |
Compositions and methods related to immunoglobulin proteases and fusions thereof
|
WO2024038002A1
(en)
|
2022-08-15 |
2024-02-22 |
F. Hoffmann-La Roche Ag |
Prevention or mitigation of adverse effects related to recombinant viral vectors
|
AU2023342254A1
(en)
|
2022-09-12 |
2025-01-23 |
F. Hoffmann-La Roche Ag |
Method for separating full and empty aav particles
|
AU2024216670A1
(en)
|
2023-02-07 |
2025-07-31 |
F. Hoffmann-La Roche Ag |
Method for the detection of anti-aav particle antibodies
|
WO2024194280A1
(en)
|
2023-03-21 |
2024-09-26 |
F. Hoffmann-La Roche Ag |
Method for the production of recombinant aav particle preparations
|
WO2024213596A1
(en)
|
2023-04-13 |
2024-10-17 |
F. Hoffmann-La Roche Ag |
Improved recombinant polyadenylation signal sequences and use thereof
|
WO2025057182A1
(en)
*
|
2023-09-15 |
2025-03-20 |
Indian Institute Of Technology Kanpur |
Modified aav vectors for enhanced gene therapy in hemophilia b
|
WO2025082618A1
(en)
|
2023-10-20 |
2025-04-24 |
Fuse Vectors Aps |
In vitro parvovirus capsid manufacturing
|
WO2025168663A1
(en)
|
2024-02-09 |
2025-08-14 |
F. Hoffmann-La Roche Ag |
Method for producing recombinant adeno-associated viral particles
|